The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.
Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.
MRI is an essential tool for diagnosing and managing the disease, but poor image quality and interpretation variability continue to hinder its widespread adoption
Ivenia ABUS Premium was designed to help streamline the supplemental breast ultrasound workloads and enhance diagnoses by improving ease of use and image reproducibility.
Using a left radial artery approach in the cath lab exposes interventional cardiologists to significantly less radiation than a hyper-adducted right radial artery approach. The difference is substantial enough for researchers to declare LRA "the primary access site for cardiac catheterization."
S. Chris Malaisrie, MD, professor of surgery at Northwestern University, explained what these data can tell us about the lifetime management of patients who require aortic valve replacement.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
The American public’s trust in healthcare institutions, long a matter of common courtesy, fell off a cliff after the COVID-19 crisis. Two academic physicians propose a treatment pathway for the injured patient—aka our healthcare system’s reputation for reliability.
![The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.](/sites/default/files/styles/stack_views/public/2024-12/screenshot_2024-12-02_at_11.07.21_am.png.webp?itok=WCWcIaTj)
